concept

DEMYELINATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DEMYELINATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

331Connections

1Hypotheses

1Analyses

50Outgoing

50Incoming

0Experiments

1Debates

Summary

DEMYELINATION is a concept in neurodegeneration research. Key relationships include: co discussed, associated with, causes. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 73 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DEMYELINATION
Key Genes/Proteins	ABCA1, AQP4
Related Diseases	aging, ALS, ALZHEIMER, Alzheimer'S Disease, ALZHEIMER'S DISEASE

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Demyelination

mechanism · 3212 words

→

Pathway Diagram

graph TD
    DEMYELINATION["DEMYELINATION"]
    DEMYELINATION -->|"expressed in"| NEURON["NEURON"]
    DEMYELINATION -->|"expressed in"| NEURONS["NEURONS"]
    DEMYELINATION -->|"expressed in"| OLIGODENDROCYTE["OLIGODENDROCYTE"]
    DEMYELINATION -->|"expressed in"| OLIGODENDROCYTES["OLIGODENDROCYTES"]
    DEMYELINATION -->|"activates"| MICROGLIA["MICROGLIA"]
    DEMYELINATION -->|"causes"| MYELINATION["MYELINATION"]
    DEMYELINATION -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
    DEMYELINATION -->|"causes"| INFLAMMATION["INFLAMMATION"]
    DEMYELINATION -->|"causes"| MULTIPLE_SCLEROSIS["MULTIPLE SCLEROSIS"]
    MS["MS"] -->|"causes"| DEMYELINATION
    Multiple_Sclerosis["Multiple Sclerosis"] -->|"causes"| DEMYELINATION
    AQP4_Antibody_Positive_NMOSD["AQP4-Antibody-Positive NMOSD"] -->|"involved_in"| DEMYELINATION
    MOGAD["MOGAD"] -->|"involved_in"| DEMYELINATION
    Classical_Complement_Cascade["Classical Complement Cascade"] -->|"causes"| DEMYELINATION
    Astrocyte_Injury["Astrocyte Injury"] -->|"contributes to"| DEMYELINATION
    BMPR1A["BMPR1A"] -->|"causes"| DEMYELINATION
    GPX4["GPX4"] -->|"causes"| DEMYELINATION
    ASK1["ASK1"] -->|"involved_in"| DEMYELINATION
    C9ORF72DIPEPTIDEREPEATPROTEINS["C9ORF72DIPEPTIDEREPEATPROTEINS"] -->|"causes"| DEMYELINATION
    INFLAMMATION -->|"causes"| DEMYELINATION

Outgoing (129)

Target	Relation	Type	Str
NEUROMYELITIS OPTICA SPECTRUM DISORDER	involved_in	entity	0.95
MULTIPLE SCLEROSIS	involved_in	entity	0.95
MOGAD	involved_in	entity	0.95
Reduced Signal Conduction	causes	phenotype	0.90
Multiple Sclerosis	biomarker_for	disease	0.90
Neuronal Loss	contributes_to	process	0.85
Postoperative neurocognitive disorder	contributes_to	disease	0.80
NEURON	activates	cell_type	0.80
REMYELINATION	exacerbates	phenotype	0.70
TREM2	causes	gene	0.65
NEURODEGENERATION	triggers	process	0.65
NEUROINFLAMMATION	interacts_with	phenotype	0.65
ISCHEMIA	regulates	disease	0.65
NEURON	associated_with	cell_type	0.65
OLIGODENDROCYTES	activates	cell_type	0.65
MBP	regulates	gene	0.65
NEURODEGENERATION	protects_against	disease	0.65
MITOCHONDRIAL DYSFUNCTION	exacerbates	phenotype	0.65
CYTOKINES	targets	phenotype	0.65
NEURONS	inhibits	cell_type	0.65
NEURODEGENERATION	destabilizes	phenotype	0.60
AXL	depleted_in	gene	0.55
CENTRAL NERVOUS SYSTEM	associated_with	concept	0.50
SEEDING	co_discussed	entity	0.50
JAK	co_discussed	entity	0.50
SYNAPSE	co_discussed	entity	0.50
T CELL	co_discussed	entity	0.50
SPINAL CORD	co_discussed	entity	0.50
TDP-43	co_discussed	entity	0.50
OLIGODENDROCYTES	co_discussed	entity	0.50
PYROPTOSIS	co_discussed	entity	0.50
COMPLEMENT CASCADE	activates	pathway	0.50
RETINA	associated_with	brain_region	0.50
GFAP	co_discussed	entity	0.50
MULTIPLE SCLEROSIS	co_discussed	entity	0.50
MACROPHAGE	co_discussed	entity	0.50
MACROPHAGES	co_discussed	entity	0.50
WHITE MATTER	co_discussed	entity	0.50
OXIDATIVE STRESS	co_discussed	entity	0.50
NLRP3	co_discussed	entity	0.50
REMYELINATION	activates	process	0.50
WHITE MATTER	activates	brain_region	0.50
Cognitive Impairment	activates	phenotype	0.50
CENTRAL NERVOUS SYSTEM	interacts_with	concept	0.50
GLIOSIS	activates	concept	0.50
MICROGLIAL ACTIVATION	activates	concept	0.50
LIPID METABOLISM	co_discussed	entity	0.50
TLR4	co_discussed	entity	0.50
ER STRESS	co_discussed	entity	0.50
SLEEP	co_discussed	entity	0.50

Incoming (202)

Source	Relation	Type	Str
MS	causes	disease	1.00
Progressive Multiple Sclerosis	associated_with	disease	0.95
Multiple Sclerosis	associated_with	disease	0.95
Multiple Sclerosis	causes	disease	0.90
MOG-Associated Disease	associated_with	disease	0.90
Immune-Glia Interactions	mediates	mechanism	0.90
COMPLEMENT C3	contributes_to	protein	0.90
AQP4	implicated_in	protein	0.90
MOG	implicated_in	protein	0.90
Inflammatory Infiltrates	causes	cell_type	0.85
Astrocyte Injury	contributes_to	process	0.85
Soluble Factors	associated_with	compound	0.85
Astrocytic Mitochondrial Dysfunction	causes	mechanism	0.85
Central Nervous System Inflammation	causes	process	0.85
AQP4-Positive NMOSD	involved_in	disease	0.85
Classical Complement Cascade	causes	pathway	0.85
Oligodendrocyte Lineage Cells	contributes_to	cell_type	0.85
MOGAD	involved_in	disease	0.85
AQP4-Antibody-Positive NMOSD	involved_in	disease	0.85
Microglia	contributes_to	cell_type	0.85
complement cascade	mediates	pathway	0.85
Astrocytes	contributes_to	cell_type	0.85
SPG7	associated_with	gene	0.80
Oligodendrocyte Lineage Cells	mediates	cell_type	0.80
BMPR1A	causes	gene	0.80
PLA2G6	associated_with	gene	0.80
GPX4	causes	gene	0.80
Astrocytes	mediates	cell_type	0.80
KCNQ2PROTEIN	associated_with	protein	0.80
ERLIN1	associated_with	gene	0.80
Oxidative Injury	contributes_to	process	0.80
ASK1	involved_in	protein	0.80
oligodendrocytes	implicated_in	cell_type	0.80
ASK1	contributes_to	gene	0.80
ASTROCYTE	causes	cell_type	0.80
Microglia	mediates	cell_type	0.75
C9ORF72DIPEPTIDEREPEATPROTEINS	causes	protein	0.70
CTNNA2	associated_with	gene	0.70
TH	inhibits	gene	0.70
OLIGODENDROCYTE	treats	cell_type	0.70
OLIGODENDROCYTE	stabilizes	cell_type	0.70
PRKAA1	associated_with	gene	0.70
ER stress	causes	pathway	0.70
OLIGODENDROCYTES	destabilizes	cell_type	0.70
CORPUS CALLOSUM	activates	brain_region	0.65
NLRP3 INFLAMMASOME	activates	pathway	0.65
NLRP3	activates	gene	0.65
T CELLS	protects_against	cell_type	0.65
TAU	activates	protein	0.65
ALZHEIMER'S DISEASE	interacts_with	disease	0.65

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
MOG-IgG induces spinal cord demyelination through Fcγ recept	0.560	neuroinflammation	What are the specific pathophysiological

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why do clinical manifestations overlap despite distinct underlying etiologies in

neuroinflammation | 2026-04-08 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The abstract notes that clinical presentations overlap across different myelopat

closed · Rounds: 4 · Score: 0.86 · 2026-04-09

Related Research

Hypotheses and analyses mentioning DEMYELINATION in their description or question text

No additional research found